Dissection of drug-binding-induced conformational changes in P-glycoprotein

Guichun Wang, Roxana Pincheira, Jian-Ting Zhang

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

P-glycoprotein (Pgp) is a membrane-transport ATPase. It uses energy from ATP hydrolysis to transport pleiotropic cytotoxic drugs from inside to outside of cells. Thus, elevated expression of Pgp in cancer cells causes multidrug resistance. It is now known that the conformational state of Pgp changes during its catalytic cycle. However, how ATP hydrolysis relates to drug binding by Pgp is yet to be determined. in this study, we used limited trypsin digestion of Pgp in isolated inside-out membrane vesicles to investigate the effects of drugs on Pgp conformation and to determine the drug-bound conformational states of Pgp in the catalytic cycle. We found that (a) binding of vinblastine or verapamil alone can cause a conformational change in Pgp, but the change induced by the drug binding is different from that induced by nucleotide binding, (b) there may be at least two binding sites for Pgp substrates, one for drugs such as vinblastine and verapamil and the other for drugs such as colchicine and adriamycin, (c) the conformation of Pgp bound by ATP and vinblastine is different from the conformation bound by either one alone, and (d) the ADP-bound Pgp does not bind vinblastine. Based on these observations and our previous studies, we propose a model for drug binding and transport in the catalytic cycle of Pgp.

Original languageEnglish
Pages (from-to)383-390
Number of pages8
JournalEuropean Journal of Biochemistry
Volume255
Issue number2
DOIs
StatePublished - Jul 15 1998

Fingerprint

Dissection
P-Glycoprotein
Pharmaceutical Preparations
Vinblastine
Conformations
Adenosine Triphosphate
Verapamil
Hydrolysis
Membranes
Colchicine
Multiple Drug Resistance
Doxorubicin
Adenosine Diphosphate
Trypsin
Adenosine Triphosphatases
Digestion
Nucleotides

Keywords

  • Conformational change
  • Multidrug resistance
  • P-glycoprotein
  • Proteolysis profile
  • Topology

ASJC Scopus subject areas

  • Biochemistry

Cite this

Dissection of drug-binding-induced conformational changes in P-glycoprotein. / Wang, Guichun; Pincheira, Roxana; Zhang, Jian-Ting.

In: European Journal of Biochemistry, Vol. 255, No. 2, 15.07.1998, p. 383-390.

Research output: Contribution to journalArticle

Wang, Guichun ; Pincheira, Roxana ; Zhang, Jian-Ting. / Dissection of drug-binding-induced conformational changes in P-glycoprotein. In: European Journal of Biochemistry. 1998 ; Vol. 255, No. 2. pp. 383-390.
@article{e6dab0a4cd8a4a499effd2b9b7bf0689,
title = "Dissection of drug-binding-induced conformational changes in P-glycoprotein",
abstract = "P-glycoprotein (Pgp) is a membrane-transport ATPase. It uses energy from ATP hydrolysis to transport pleiotropic cytotoxic drugs from inside to outside of cells. Thus, elevated expression of Pgp in cancer cells causes multidrug resistance. It is now known that the conformational state of Pgp changes during its catalytic cycle. However, how ATP hydrolysis relates to drug binding by Pgp is yet to be determined. in this study, we used limited trypsin digestion of Pgp in isolated inside-out membrane vesicles to investigate the effects of drugs on Pgp conformation and to determine the drug-bound conformational states of Pgp in the catalytic cycle. We found that (a) binding of vinblastine or verapamil alone can cause a conformational change in Pgp, but the change induced by the drug binding is different from that induced by nucleotide binding, (b) there may be at least two binding sites for Pgp substrates, one for drugs such as vinblastine and verapamil and the other for drugs such as colchicine and adriamycin, (c) the conformation of Pgp bound by ATP and vinblastine is different from the conformation bound by either one alone, and (d) the ADP-bound Pgp does not bind vinblastine. Based on these observations and our previous studies, we propose a model for drug binding and transport in the catalytic cycle of Pgp.",
keywords = "Conformational change, Multidrug resistance, P-glycoprotein, Proteolysis profile, Topology",
author = "Guichun Wang and Roxana Pincheira and Jian-Ting Zhang",
year = "1998",
month = "7",
day = "15",
doi = "10.1046/j.1432-1327.1998.2550383.x",
language = "English",
volume = "255",
pages = "383--390",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Dissection of drug-binding-induced conformational changes in P-glycoprotein

AU - Wang, Guichun

AU - Pincheira, Roxana

AU - Zhang, Jian-Ting

PY - 1998/7/15

Y1 - 1998/7/15

N2 - P-glycoprotein (Pgp) is a membrane-transport ATPase. It uses energy from ATP hydrolysis to transport pleiotropic cytotoxic drugs from inside to outside of cells. Thus, elevated expression of Pgp in cancer cells causes multidrug resistance. It is now known that the conformational state of Pgp changes during its catalytic cycle. However, how ATP hydrolysis relates to drug binding by Pgp is yet to be determined. in this study, we used limited trypsin digestion of Pgp in isolated inside-out membrane vesicles to investigate the effects of drugs on Pgp conformation and to determine the drug-bound conformational states of Pgp in the catalytic cycle. We found that (a) binding of vinblastine or verapamil alone can cause a conformational change in Pgp, but the change induced by the drug binding is different from that induced by nucleotide binding, (b) there may be at least two binding sites for Pgp substrates, one for drugs such as vinblastine and verapamil and the other for drugs such as colchicine and adriamycin, (c) the conformation of Pgp bound by ATP and vinblastine is different from the conformation bound by either one alone, and (d) the ADP-bound Pgp does not bind vinblastine. Based on these observations and our previous studies, we propose a model for drug binding and transport in the catalytic cycle of Pgp.

AB - P-glycoprotein (Pgp) is a membrane-transport ATPase. It uses energy from ATP hydrolysis to transport pleiotropic cytotoxic drugs from inside to outside of cells. Thus, elevated expression of Pgp in cancer cells causes multidrug resistance. It is now known that the conformational state of Pgp changes during its catalytic cycle. However, how ATP hydrolysis relates to drug binding by Pgp is yet to be determined. in this study, we used limited trypsin digestion of Pgp in isolated inside-out membrane vesicles to investigate the effects of drugs on Pgp conformation and to determine the drug-bound conformational states of Pgp in the catalytic cycle. We found that (a) binding of vinblastine or verapamil alone can cause a conformational change in Pgp, but the change induced by the drug binding is different from that induced by nucleotide binding, (b) there may be at least two binding sites for Pgp substrates, one for drugs such as vinblastine and verapamil and the other for drugs such as colchicine and adriamycin, (c) the conformation of Pgp bound by ATP and vinblastine is different from the conformation bound by either one alone, and (d) the ADP-bound Pgp does not bind vinblastine. Based on these observations and our previous studies, we propose a model for drug binding and transport in the catalytic cycle of Pgp.

KW - Conformational change

KW - Multidrug resistance

KW - P-glycoprotein

KW - Proteolysis profile

KW - Topology

UR - http://www.scopus.com/inward/record.url?scp=0032528075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032528075&partnerID=8YFLogxK

U2 - 10.1046/j.1432-1327.1998.2550383.x

DO - 10.1046/j.1432-1327.1998.2550383.x

M3 - Article

VL - 255

SP - 383

EP - 390

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

IS - 2

ER -